Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840.
Seidman AD, Berry D, Cirrincione C, Harris L, Muss H, Marcom PK, Gipson G, Burstein H, Lake D, Shapiro CL, Ungaro P, Norton L, Winer E, Hudis C. Seidman AD, et al. Among authors: ungaro p. J Clin Oncol. 2008 Apr 1;26(10):1642-9. doi: 10.1200/JCO.2007.11.6699. J Clin Oncol. 2008. PMID: 18375893 Clinical Trial.
Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.
Socinski MA, Blackstock AW, Bogart JA, Wang X, Munley M, Rosenman J, Gu L, Masters GA, Ungaro P, Sleeper A, Green M, Miller AA, Vokes EE. Socinski MA, et al. Among authors: ungaro p. J Clin Oncol. 2008 May 20;26(15):2457-63. doi: 10.1200/JCO.2007.14.7371. J Clin Oncol. 2008. PMID: 18487565 Clinical Trial.
Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancer.
Maguire PD, Papagikos M, Hamann S, Neal C, Meyerson M, Hayes N, Ungaro P, Kotz K, Couch M, Pollock H, Tepper J. Maguire PD, et al. Among authors: ungaro p. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1081-8. doi: 10.1016/j.ijrobp.2009.12.046. Epub 2010 Apr 8. Int J Radiat Oncol Biol Phys. 2011. PMID: 20378262 Free PMC article. Clinical Trial.
Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community.
Maguire PD, Meyerson MB, Neal CR, Hamann MS, Bost AL, Anagnost JW, Ungaro PC, Pollock HD, McMurray JE, Wilson EP, Kotwall CA. Maguire PD, et al. Among authors: ungaro pc. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):698-704. doi: 10.1016/S0360-3016(03)01576-1. Int J Radiat Oncol Biol Phys. 2004. PMID: 14967423
Another look at thyroid nodules.
Werk EE Jr, Gonzalez JJ, Ungaro PC. Werk EE Jr, et al. Among authors: ungaro pc. N C Med J. 1988 Feb;49(2):81-2. N C Med J. 1988. PMID: 3422710 No abstract available.
Historic paint.
Gonzalez JJ, Ungaro PC. Gonzalez JJ, et al. Among authors: ungaro pc. N C Med J. 1982 Dec;43(12):845-7. N C Med J. 1982. PMID: 6961283 No abstract available.
82 results